Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
NIP header
Family
NIP:
bullet NIP HOME
bullet First time visitor?
bullet About NIP
bullet Data and Statistics
bullet International Efforts
bullet Links to other web sites 
bullet Glossary/ Acronyms 

NIP sub-sites:
bullet ACIP
bullet Flu Vaccine
bullet Immunization Registries
bullet Vaccines for Children Program
bullet CASA (Clinic Assessment Program)
bullet AFIX (Grantee Assessment)
bullet VACMAN
 

NIP Site Search
 
For Immunization Information, call the
CDC-INFO Contact Center:
English and Spanish
800-CDC-INFO
800-232-4636
TTY
888-232-6348

Get Acrobat Reader
Get Adobe Reader
 

Vaccine Safety > Hepatitis B
Hepatitis B

Related pages:


A Message from NIP's Director
Infant, adolescent, and adult immunization plays an important role in disease prevention and reduction. Although no vaccine is perfect, the benefits of immunization far outweigh the risks. Thanks to vaccines, fewer cases of vaccine-preventable diseases were reported in 1998 than in any previous year. In addition, recent changes in the nation’s vaccine recommendations have made immunizations even safer. 

The National Immunization Program is committed to strengthening vaccine programs and further improving disease prevention. Vaccine safety is constantly monitored and vaccine safety concerns are being investigated and addressed. 

Today, thanks to their relative rarity, it is easy to forget that vaccine preventable diseases can cause lasting brain damage, liver cancer, paralysis, and premature death. It is important to remember, however, vaccines are the primary reason there are so few cases of such childhood diseases as measles, whooping cough, rubella (German measles), and hepatitis B.

Listed below are links that will provide you with more information about hepatitis B vaccine.

  1. General information on hepatitis B vaccine
  2. Questions and answers on hepatitis B vaccine
  3. Facts on Hepatitis B Disease
  4. CDC testimony before the U.S. House of Representatives on hepatitis B disease and the vaccine (5/18/99)
  5. FDA testimony before the U.S. House of Representatives on hepatitis B disease and the vaccine (5/18/99)

Walter A. Orenstein, M.D.
Assistant Surgeon General
Director
National Immunization Program
Centers for Disease Control and Prevention

Top of page


National Immunization Program (NIP)
NIP Home | Contact Us | Help | Glossary | About | Accessibility

This page last modified on February 11, 2003
This page last reviewed on March 28, 2000

   

Department of Health and Human Services
Centers for Disease Control and Prevention
CDC Home
  |  CDC Search  |  CDC Health Topics A-Z